Nureca Limited has informed the Exchange regarding a press release dated July 15, 2025, titled " Nureca Limited reports 70% YoYgrowth for Q1 FY26, Highest Revenue in last consecutive 10 Quarters, Outpacingeven Seasonal Peaks ".
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited reported a 70% year-on-year jump in revenue for Q1 FY26 (quarter ended June 30, 2025), reaching ₹34.18 crore compared to ₹20.27 crore in Q1 FY25. This marks the company's highest quarterly revenue in the last 10 consecutive quarters, even surpassing typical seasonal peaks. On a quarter-on-quarter basis, revenue grew 8% from ₹31.7 crore in Q4 FY25. The home healthcare and wellness company attributed the performance to innovation, operational efficiency, and expanded product availability across channels.
Strong top-line growth and a 10-quarter revenue high signal robust business momentum, which is likely to be viewed positively by investors. However, investors should watch for margin trends and profitability details in the full results, as the press release highlights only revenue.